Enhanced expression of trim14 gene suppressed Sindbis virus reproduction and modulated the transcription of a large number of genes of innate immunity

Immunologic Research

Volumn 62, Issue 3, 2015, Pages 255-262

  Nenasheva, V V ^a   Kovaleva, G V ^a   Uryvaev, L V ^b   Ionova, K S ^b   Dedova, A V ^b   Vorkunova, G K ^b   Chernyshenko, S V ^c   Khaidarova, N V ^a   Tarantul, V Z ^a  

^a INSTITUTE OF MOLECULAR GENETICS   (Russian Federation)

^b N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

^c University of Koblenz   (Germany)

Author keywords

Alphavirus Sindbis; Antiviral defense; Innate immunity genes; TRIM14

Indexed keywords

GAMMA INTERFERON; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; PROTEIN C MYB; PROTEIN KINASE TYK2; RAF PROTEIN; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR JUNB; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB; CARRIER PROTEIN; TRIM14 PROTEIN, HUMAN;

AKT1 GENE; ALPHAVIRUS INFECTION; ARTICLE; CONTROLLED STUDY; EMBRYO; ERK2 GENE; GATA1 GENE; GENE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC TRANSFECTION; GRB2 GENE; GRB3 3 GENE; HUMAN; HUMAN CELL; IFN GAMMA GENE; IFNA GENE; IL 17A GENE; IL6 GENE; INNATE IMMUNITY; ISG15 GENE; MEK2 GENE; NF KAPPAB1 GENE; NF KAPPAB2 GENE; NONHUMAN; ONCOGENE C JUN; ONCOGENE C MYB; PRIORITY JOURNAL; PROTEIN PROCESSING; PU 1 GENE; RAF 1 GENE; RELA GENE; RELB GENE; SINDBIS VIRUS; TRAF3IP2 GENE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TRIM14 GENE; TYK2 GENE; VIRUS INHIBITION; VIRUS STRAIN; BIOSYNTHESIS; CELL LINE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEK293 CELL LINE; HOST PATHOGEN INTERACTION; IMMUNOLOGY; VIROLOGY; VIRUS REPLICATION;

ALPHAVIRUS INFECTIONS; CARRIER PROTEINS; CELL LINE; HEK293 CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; SINDBIS VIRUS; TRANSFECTION; VIRUS REPLICATION;

EID: 84931572257     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-015-8653-1     Document Type: Article

References (44)

1. Kawai T, Akira S. Regulation of innate immune signaling pathways by 542 the tripartite motif (TRIM) family proteins. EMBO Mol Med. 2011;3:513–27.
2. McNab FW, Rajsbaum R, Stoye JP, O’Garra A. Tripartite-motif proteins and innate immune regulation. Curr Opin Immunol. 2011;23:46–56.
3. Nisole S, Stoye JP, Saib A. TRIM family proteins: retroviral restriction and animal defence. Nat Rev Microbiol. 2005;3:799–808.
4. Towers GJ. Control of viral infectivity by tripartite motif proteins. Hum Gene Ther. 2005;16:1125–32.
5. Gack MU, Shin YC, Joo CH, Urano T, Liang C, Sun L, et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-1-mediated antiviral activity. Nature. 2007;446:916–20.
6. Everett RD, Chelbi-Alex MK. PML and PML nuclear bodies: implications in antiviral defense. Biochimie. 2007;89:819–30.
7. Ozato K, Shin DM, Chang TH, Morse HC 3rd. TRIM family proteins and their emerging roles in innate immunity. Nat Rev Immunol. 2008;8:849–60.
8. Munir M. TRIM proteins: another class of viral victims. Sci Signal. 2010;3:jc2.
9. Wang J, Liu B, Wang N, Lee YM, Liu C, Li K. TRIM56 is a virus and interferon inducible E3 ubiquitin ligase that restricts pestivirus infection. J Virol. 2011;85:3733–45.
10. Grütter MG, Luban J. TRIM5 structure, HIV-1 capsid recognition, and innate immune signaling. Curr Opin Virol. 2012;2:142–50.
11. Tarantul VZ, Nikolaev AI, Martynenko A, Hannig H, Hunsmann G, Bodemer W. Differential gene expression in B-cell non-Hodgkin’s lymphoma of SIV-infected monkey. AIDS Res Hum Retroviruses. 2000;16:173–9.
12. Nenasheva V, Maksimov V, Nikolaev A, Tarantul V. Comparative analysis of the level of gene transcription in two types of HIV-associated lymphoma. Mol Gen Mikrobiol Virusol. 2001;4:27–31.
13. Nenasheva VV, Nikolaev AI, Martynenko AV, Kaplanskaya IB, Bodemer W, Hunsmann G, et al. Differential gene expression in HIV/SIV-associated and spontaneous lymphomas. Int J Med Sci. 2005;2:122–8.
14. Choi JH, Choi BS, Kim SS, Lee JS, et al. Differentially expressed cellular gene profiles between healthy HIV-infected Koreans and AIDS patients. Korean J Hematol. 2007;42:33–42.
15. Uchil PD, Quinlan BD, Chan WT, Luna JM, Mothes W. TRIM E3 ligases interfere with early and late stages of the retroviral life cycle. PLoS Pathog. 2008;4:e16.
16. Uchil PD, Hinz A, Siegel S, Coenen-Stass A, Pertel T, Luban J, et al. TRIM protein-mediated regulation of inflammatory and innate immune signaling and its association with antiretroviral activity. J Virol. 2013;87:257–72.
17. Metz P, Dazert E, Ruggieri A, Mazur J, Kaderali L, Kaul A, et al. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication. Hepatology. 2012;56:2082–93.
18. Zhou Z, Jia X, Xue Q, Dou Z, Ma Y, Zhao Z, et al. TRIM14 is a mitochondrial adaptor that facilitates retinoic acid-inducible gene-I-like receptor-mediated innate immune response. Proc Natl Acad Sci USA. 2014;111:E245–54.
19. Ramilo O, Allman W, Chung W, Mejias A, Ardura M, Glaser C, et al. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood. 2007;109:2066–77.
20. Su AI, Pezacki JP, Wodicka L, Brideau AD, Supekova L, Thimme R, et al. Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci USA. 2002;99:15669–74.
21. Chen Y, Hamati E, Lee PK, Lee WM, Wachi S, Schnurr D, et al. Rhinovirus induces airway epithelial gene expression through double-stranded RNA and IFN-dependent pathways. Am J Respir Cell Mol Biol. 2006;34:192–203.
22. Lvov DK, Uryvaev LV. Togaviruses. In: Lvov DK, editor. Manual of medical virology. Moscow: Medical Informational Agency; 2008. p. 217–24 (Russian).
23. Uryvaev LV, Vasilenko VA, Parasjuk NA, Ionova KS, Gushchina EA, Kullapere AA, et al. Isolation and identification Sindbis virus from migratory birds in Estonia. Probl Virol. 1992;1:67–74.
24. Uryvaev LV, Dedova AV, Dedova LV, Ionova KS, Parasjuk NA, Selivanova TK, et al. Contamination of cell cultures with bovine viral diarrhea virus (BVDV). Bull Exp Biol Med. 2012;53:77–81.
25. Nenasheva VV, Kovaleva GV, Khaidarova NV, Novosadova EV, Manuilova ES, Antonov SA, et al. Trim14 overexpression causes the same transcriptional changes in mouse embryonic stem cells and human HEK293 cells. In Vitro Cell Dev Biol Anim. 2014;50:121–8.
26. Griffin DE. The alphaviruses. In: Knipe DM, Howley PM, editors. Fields virology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 1023–67.
27. Yin J, Gardner CL, Burke CW, Ryman KD, Klimstra WB, et al. Similarities and differences in antagonism of neuron alpha/beta interferon responses by Venezuelan equine encephalitis and Sindbis alphaviruses. J Virol. 2009;83:10036–47.
28. Després P, Griffin JW, Griffin DE. Antiviral activity of alpha interferon in Sindbis virus-infected cells is restored by anti-E2 monoclonal antibody treatment. J Virol. 1995;69:7345–8.
29. Czarniecki CW, Allen PT. Disparate response of encephalomyocarditis virus and MM virus to interferon in JLS-V9R cells. Antivir Res. 1984;4:351–5.
30. Grieder FB, Vogel SN. Role of interferon and IFN regulatory factors in early protection against VEE virus infection. Virology. 1999;257:106–18.
31. Baker RG, Hayden MS, Ghosh S. NF-κB, inflammation, and metabolic disease. Cell Metab. 2011;13:11–22.
32. Bonadies N, Neururer Ch, Steege A, Vallabhapurapu S, Pabst T, Mueller BU. PU.1 is regulated by NF-κB through a novel binding site in a 17 kb upstream enhancer element NF-κB regulates PU.1 through a distal element. Oncogene. 2010;29:1062–72.
33. Rehli M, Poltorak A, Schwarzfischer L, Krause SW, Andreesen R, Beutler B. PU.1 and interferon consensus sequence-binding protein regulate the myeloid expression of the human Toll-like receptor 4 gene. J Biol Chem. 2000;275:9773–81.
34. Hirano T. Interleukin 6 and its receptor: ten years later. Int Rev Immunol. 1998;16:249–84.
35. Baccarini M. Second nature: biological functions of the Raf-1 “kinase”. FEBS Lett. 2005;579:3271–7.
36. Li X. Act1 modulates autoimmunity through its dual functions in CD40L/BAFF and IL-17 signaling. Cytokine. 2008;41:105–13.
37. Cheng J, Phong B, Wilson DC, Hirsch R, Kane LP. Akt fine-tunes NF-κB-dependent gene expression during T cell activation. J Biol Chem. 2011;286:36076–85.
38. de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. 2006;6:24–37.
39. Marcus PI, Fuller FJ. Interferon induction by viruses. II. Sindbis virus: interferon induction requires one-quarter of the genome-genes G and A. J Gen Virol. 1979;44:169–77.
40. Hidmark AS, McInerney GM, Nordstrom EK, Douagi I, Werner KM, Liljeström P, et al. Early alpha/beta interferon production by myeloid dendritic cells in response to UV-inactivated virus requires viral entry and interferon regulatory factor 3 but not MyD88. JVirol. 2005;79:10376–85.
41. Iwasaki A, Medzhitov R. Innate responses to viral infections. In: Knipe DM, Howley PM, editors. Fields Virology. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2013. p. 189–213.
42. Lenschow DJ, Giannakopoulos NV, Gunn LJ, Johnston C, O’Guin AK, Schmidt RE, et al. Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo. J Virol. 2005;79:13974–83.
43. Breakwell L, Dosenovic P, Karlsson Hedestram GB, D’Amato M, Liljeström P, Fazakerley J, et al. SFV nsP2 protein is involved in suppression of type I IFN response. J Virol. 2007;81:8677–84.
44. Gorchakov R, Frolova E, Frolov I. Inhibition of transcription and translation in Sindbis virus-infected cells. J Virol. 2005;79:9397–409.